The case for complement component 5 as a target in neurodegenerative disease

Amelia Stennetta School of Natural and Environmental Sciences, Newcastle University, NE1 7RU, Newcastle-Upon-Tyne, UKView further author information

Kallie Fristona School of Natural and Environmental Sciences, Newcastle University, NE1 7RU, Newcastle-Upon-Tyne, UKView further author information

Claire L. Harrisb Faculty of Medical Sciences, Newcastle University, NE2 4HH, Newcastle-Upon-Tyne, UKView further author information

Adam J. M. Wollmanb Faculty of Medical Sciences, Newcastle University, NE2 4HH, Newcastle-Upon-Tyne, UKView further author information

Agnieszka K. Bronowskaa School of Natural and Environmental Sciences, Newcastle University, NE1 7RU, Newcastle-Upon-Tyne, UKView further author information

Katrina S. Maddena School of Natural and Environmental Sciences, Newcastle University, NE1 7RU, Newcastle-Upon-Tyne, UK;b Faculty of Medical Sciences, Newcastle University, NE2 4HH, Newcastle-Upon-Tyne, UKCorrespondence[email protected]

https://orcid.org/0000-0002-3834-148X View further author information

The case for complement component 5 as a target in neurodegenerative disease

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The case for complement component 5 as a target in neurodegenerative disease

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date